Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matteo Ferro

Showing results (291-300 of 420) with videos related to

Pageof 42
Sort By:
Oncology and Therapy|June 11, 2026
Beyond the BCG Paradox: Biological Rationale and Clinical Evidence for Combining Intravesical BCG with Immune Checkpoint Inhibitors in High-Risk Non-muscle-Invasive Bladder CancerMichele Musone, Biagio Barone, Stefano Chianese, et al.
Critical Reviews in Oncology/Hematology|December 14, 2020
First-line systemic therapy for metastatic castration-sensitive prostate cancer: An updated systematic review with novel findingsMatteo Ferro, Giuseppe Lucarelli, Felice Crocetto, et al.
Nutrients|August 26, 2023
Novel Key Ingredients in Urinary Tract Health-The Role of D-mannose, Chondroitin Sulphate, Hyaluronic Acid, and <i>N</i>-acetylcysteine in Urinary Tract Infections (Uroial PLUS<sup>®</sup>)Felice Crocetto, Raffaele Balsamo, Ugo Amicuzi, et al.
Critical Reviews in Oncology/Hematology|June 23, 2023
Comparing cardiovascular adverse events in cancer patients: A meta-analysis of combination therapy with angiogenesis inhibitors and immune checkpoint inhibitors versus angiogenesis inhibitors aloneFelice Crocetto, Matteo Ferro, Carlo Buonerba, et al.
Journal of Endourology|October 21, 2020
Safety and Feasibility of Outpatient Surgery in Benign Prostatic Hyperplasia: a Systematic Review and Meta-AnalysisStefano Salciccia, Francesco Del Giudice, Martina Maggi, et al.
European Urology Focus|November 8, 2017
Robot-assisted Partial Nephrectomy: 5-yr Oncological Outcomes at a Single European Tertiary Cancer CenterMihai Dorin Vartolomei, Deliu Victor Matei, Giuseppe Renne, et al.
Translational Andrology and Urology|February 3, 2021
Impact of uni- or multifocal perineural invasion in prostate cancer at radical prostatectomyAlessandro Sciarra, Martina Maggi, Arianna Del Proposto, et al.
Annals of Surgical Oncology|July 30, 2025
ASO Author Reflections: History of Valvulopathy: Effect on Adverse In-Hospital Outcomes After Partial and Radical NephrectomyCalogero Catanzaro, Fabian Falkenbach, Andrea Marmiroli, et al.
Journal of Surgical Oncology|August 26, 2024
Effect of race/ethnicity on survival in surgically treated intermediate/high risk non-metastatic clear cell renal carcinomaMattia Luca Piccinelli, Cristina Cano Garcia, Andrea Panunzio, et al.
Journal of Surgical Oncology|June 13, 2025
Cancer-Specific Survival of Trimodal Therapy Versus Radical Cystectomy in T2N0M0 Non-Urothelial Bladder CancerMattia Longoni, Andrea Marmiroli, Fabian Falkenbach, et al.
Pageof 42

Showing results (291-300 of 420) with videos related to

Sort By:
Pageof 42
Oncology and Therapy|June 11, 2026
Beyond the BCG Paradox: Biological Rationale and Clinical Evidence for Combining Intravesical BCG with Immune Checkpoint Inhibitors in High-Risk Non-muscle-Invasive Bladder CancerMichele Musone, Biagio Barone, Stefano Chianese, et al.
Critical Reviews in Oncology/Hematology|December 14, 2020
First-line systemic therapy for metastatic castration-sensitive prostate cancer: An updated systematic review with novel findingsMatteo Ferro, Giuseppe Lucarelli, Felice Crocetto, et al.
Nutrients|August 26, 2023
Novel Key Ingredients in Urinary Tract Health-The Role of D-mannose, Chondroitin Sulphate, Hyaluronic Acid, and <i>N</i>-acetylcysteine in Urinary Tract Infections (Uroial PLUS<sup>®</sup>)Felice Crocetto, Raffaele Balsamo, Ugo Amicuzi, et al.
Critical Reviews in Oncology/Hematology|June 23, 2023
Comparing cardiovascular adverse events in cancer patients: A meta-analysis of combination therapy with angiogenesis inhibitors and immune checkpoint inhibitors versus angiogenesis inhibitors aloneFelice Crocetto, Matteo Ferro, Carlo Buonerba, et al.
Journal of Endourology|October 21, 2020
Safety and Feasibility of Outpatient Surgery in Benign Prostatic Hyperplasia: a Systematic Review and Meta-AnalysisStefano Salciccia, Francesco Del Giudice, Martina Maggi, et al.
European Urology Focus|November 8, 2017
Robot-assisted Partial Nephrectomy: 5-yr Oncological Outcomes at a Single European Tertiary Cancer CenterMihai Dorin Vartolomei, Deliu Victor Matei, Giuseppe Renne, et al.
Translational Andrology and Urology|February 3, 2021
Impact of uni- or multifocal perineural invasion in prostate cancer at radical prostatectomyAlessandro Sciarra, Martina Maggi, Arianna Del Proposto, et al.
Annals of Surgical Oncology|July 30, 2025
ASO Author Reflections: History of Valvulopathy: Effect on Adverse In-Hospital Outcomes After Partial and Radical NephrectomyCalogero Catanzaro, Fabian Falkenbach, Andrea Marmiroli, et al.
Journal of Surgical Oncology|August 26, 2024
Effect of race/ethnicity on survival in surgically treated intermediate/high risk non-metastatic clear cell renal carcinomaMattia Luca Piccinelli, Cristina Cano Garcia, Andrea Panunzio, et al.
Journal of Surgical Oncology|June 13, 2025
Cancer-Specific Survival of Trimodal Therapy Versus Radical Cystectomy in T2N0M0 Non-Urothelial Bladder CancerMattia Longoni, Andrea Marmiroli, Fabian Falkenbach, et al.
Pageof 42